Soligenix (SNGX) shares were up 114% in Wednesday premarket activity after the company said its vaccine platform is suitable for the rapid development of a Bundibugyo virus treatment.
Founder Group (FGL) stock was 55% higher, building on a 2.7% rise in the previous session.
Momentus (MNTS) shares were up 40%, extending Tuesday's 109% rally in line with a broader move in space stocks.
NanoViricides (NNVC) stock was 36% higher, a day after the company said its NV-387 antiviral drug candidate is ready to be shipped to the Democratic Republic of Congo as potential Ebola treatment.
Netcapital (NCPL) shares were up 35%, adding to a 30% rally in the previous session.
Comments